<ul><li>MEnera is a new FDA-approved OTC medication targeting hormonal and reproductive conditions, valued at $44 million in the U.S. market.</li><li>Formulated by Dr. Sheryene Tejeda, MEnera aims to restore hormonal balance, regulate menstrual cycles, relieve menopausal symptoms, and improve fertility.</li><li>MEnera addresses biological dysfunctions at their source through a proprietary blend of biologically active cells, offering a unique approach to reproductive health.</li><li>Developed by Medicinal Technologies, MEnera reflects a broader mission of providing science-driven medical solutions for gynecology, oncology, ophthalmology, and endocrinology.</li></ul>

A Science-Driven Shift in Women’s Health: New OTC Medication MEnera Targets Hormonal and Reproductive Conditions

Discover more